Cytokinetics Inc logo

Cytokinetics Inc

1
3
NAS:CYTK (USA)   Ordinary Shares
$ 56.80 -0.58 (-1.01%) 11:09 PM EST
At Loss
Volume:
910.04K
Avg Vol (2M):
2.08M
Trade In:
Volume:
910.04K
At Loss
Avg Vol (2M):
2.08M

Business Description

Cytokinetics Inc logo
Cytokinetics Inc
NAICS : 325412 SIC : 2834
ISIN : US23282W6057

Share Class Description:

CYTK: Ordinary Shares
Description
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Name Current Vs Industry Vs History
Cash-To-Debt 0.82
Equity-to-Asset -0.49
Debt-to-Equity -1.91
Debt-to-EBITDA -1.65
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.64
Distress
Grey
Safe
Beneish M-Score 10.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.64
9-Day RSI 56.62
14-Day RSI 54.89
6-1 Month Momentum % -34.08
12-1 Month Momentum % 63.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.19
Quick Ratio 7.19
Cash Ratio 6.97
Days Sales Outstanding 128.55
Days Payable 17.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.7
Shareholder Yield % -3.04

Financials (Next Earnings Date:2024-08-02 Est.)

CYTK's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CYTK

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cytokinetics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.752
EPS (TTM) ($) -5.4
Beta 0.41
Volatility % 157.17
14-Day RSI 54.89
14-Day ATR ($) 2.104673
20-Day SMA ($) 55.638
12-1 Month Momentum % 63.88
52-Week Range ($) 25.98 - 110.25
Shares Outstanding (Mil) 117.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cytokinetics Inc Filings

Filing Date Document Date Form
No Filing Data

Cytokinetics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cytokinetics Inc Frequently Asked Questions

What is Cytokinetics Inc(CYTK)'s stock price today?
The current price of CYTK is $56.80. The 52 week high of CYTK is $110.25 and 52 week low is $25.98.
When is next earnings date of Cytokinetics Inc(CYTK)?
The next earnings date of Cytokinetics Inc(CYTK) is 2024-08-02 Est..
Does Cytokinetics Inc(CYTK) pay dividends? If so, how much?
Cytokinetics Inc(CYTK) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1